Analysis of PTEN/MMAC1 alteration in neuroblastoma

Cancer Genetics and Cytogenetics

Volumn 125, Issue 2, 2001, Pages 151-155

  Moritake, Hiroshi ^a   Horii, Yoshihiro ^a   Kuroda, Hiroshi ^a   Sugimoto, Tohru ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE;

ALLELE; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 10Q; CONTROLLED STUDY; DEPHOSPHORYLATION; DNA SEQUENCE; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE DISRUPTION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; SINGLE STRAND CONFORMATION POLYMORPHISM; SOLID TUMOR; TUMOR SUPPRESSOR GENE;

ALLELES; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 10; CODON; DINUCLEOTIDE REPEATS; DNA MUTATIONAL ANALYSIS; EXONS; FRAMESHIFT MUTATION; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM PROTEINS; NEUROBLASTOMA; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN STRUCTURE, TERTIARY; PTEN PHOSPHOHYDROLASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0035034044     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00378-2     Document Type: Article

References (25)

1. Altura R.A., Maris J.M., Li H., Boyett J.M., Brodeur G.M., Look A.T. Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization. Genes Chromosom Cancer. 19:1997;176-184.
2. Takita J., Hayashi Y., Kohno T., Shiseki M., Yamaguchi N., Hanada R., Yamamoto K., Yokota J. Allelotype of neuroblastoma. Oncogene. 11:1995;1829-1834.
3. White P.S., Maris J.M., Beltinger C., Sulman E., Marshall H.N., Fujimori M., Kaufman B.A., Biegel J.A., Allen C., Hilliard C., Valentine M.B., Look A.T. Enomoto H, Sakiyama S, Brodeur GM. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA. 92:1995;5520-5524.
4. Kaneko Y., Kanda N., Maseki N., Sakurai M., Tsuchida Y., Takeda T., Okabe I., Sakurai M. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res. 47:1987;311-318.
5. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
6. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K.A., Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D.H.F., Tavtigian S.V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 15:1997;356-362.
7. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., Mak T.W. Negative regulation of PKB/AKT-dependent cell survival by the tumor suppressor PTEN. Cell. 95:1998;29-39.
8. Wang S.I., Puc J., Li J., Bruce J.N., Cairns P., Sidransky D., Parsons R. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 57:1997;4183-4186.
9. Guldberg P., Straten P.T., Birck A., Ahrenkiel V., Kirkin A.F., Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57:1997;3660-3663.
10. Rhei E., Kang L., Bogomolniy F., Federici M.G., Borgen P.I., Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 57:1997;3657-3659.
11. Cairns P., Okami K., Halachmi S., Halachmi N., Esteller M., Herman J.G., Jen J., Isaacs W.B., Bova G.S., Sidransky D. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 57:1997;4997-5000.
12. Dracopoli N.C., Harnett P., Bale S.J., Stanger B.Z., Tucker M.A., Housman D.E., Kefford R.F. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA. 86:1989;4614-4618.
13. Sugimoto T., Sawada T., Matsumura T., Kemshead J.T., Ishii T., Horii Y., Morioka H., Morita M., Reynolds C.P. Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. Cancer Res. 46:1986;4765-4769.
14. Sugimoto T., Horii Y., Hino T., Kemshead J.T., Kuroda H., Sawada T., Morioka H., Imanishi J., Inoko H. Differential susceptibility of HLA class II antigens induced by γ-Interferon in human neuroblastoma cell lines. Cancer Res. 49:1989;1824-1828.
15. Kuroda H., Sugimoto T., Ueda K., Tsuchida S., Horii Y., Inazawa J., Sato K., Sawada T. Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy. Int J Cancer. 47:1991;732-737.
16. Reynolds C.P., Biedler J.L., Spengler B.A., Reynolds D.A., Ross R.A., Frenkel E.P., Smith R.G. Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst. 76:1986;375-387.
17. Brodeur G.M., Pritchard J., Berthold F., Carlsen N.L.T., Castel V., Castleberry R.P., Bernardi B.D., Evans A.E., Favrot M., Hedborg F., Kaneko M., Kemshead J., Lampert F., Lee R.E.J., Look A.T., Pearson A.D.J., Philip T., Roald B., Sawada T., Seeger R.C., Tsuchida Y., Voute P.A. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 11:1993;1466-1477.
18. Suzuki H., Freiji D., Nusskern D.R., Okami K., Cairns P., Sidransky D., Isaacs W.B., Bova G.S. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 58:1998;204-209.
19. Gyapay G., Morissette J., Vignal A., Dib C., Fizames C., Millasseau P., Marc S., Bernardi G., Lathrop M., Weissenbach J. The 1933-1944 Genethon human genetic linkage map. Nat Genet. 7:1994;246-339.
20. Lo Sh Weisberg E., Chen L.B. Tensin. a potential link between the cytoskeleton and signal transduction Bioessays. 16:1994;817-823.
21. Ungewickell E., Ungewickell H., Holstein S.E.H., Lindner R., Prasad K., Barouch W., Martin B., Greene L.E., Eisenberg E. Role of auxilin in uncoating clathrin-coated vesicles. Nature. 378:1995;632-635.
22. Ali I.U., Schriml L.M., Dean M. Mutational spectra of PTEN/MMAC1 gene. a tumor suppressor with lipid phosphate activity J Natl Cancer Inst. 91:1999;1922-1932.
23. Georgescu M.M., Kirsch K.H., Akagi T., Shishido T., Hanafusa H. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc Natl Acad Sci USA. 96:1999;10182-10187.
24. Chi S.G., Kim H.J., Park B.J., Min H.J., Park J.H., Kim Y.W., Dong S.H., Kim B.H., Lee J.I., Chang Y.W., Chang R., Kim W.K., Yang M.H. Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease. Gastroenterology. 115:1998;1084-1089.
25. Whang Y.E., Wu X., Suzuki H., Reiter R.E., Tran C., Vessella R.L., Said J.W., Isaacs W.B., Sawyers C.L. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA. 95:1998;5246-5250.